Drug and Therapeutics Bulletin 2007;45:65-70; doi:10.1136/dtb.2007.45965
Copyright © 2007 by the BMJ Publishing Group Ltd.

This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this link to a friend Similar articles in this journal Similar articles in PubMed Add article to my folders Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Search for Related Content PubMed PubMed Citation

Self-monitoring of blood glucose in diabetes

Relevant BNF section: 6.1.6

A key aim of management in people with diabetes mellitus is to control blood glucose concentrations, in order to avoid the complications of persistently raised levels (with their attendant healthcare costs) and improve quality of life.^1,2 However, such control is associated with an increased likelihood of hypoglycaemia, particularly among patients on insulin therapy.¹ In pursuit of good glycaemic control while avoiding hypoglycaemia, self-monitoring of blood glucose is widely acknowledged as a routine part of management in patients with type 1 diabetes. However, the cost of monitoring products has now become a major issue for healthcare providers. This has led to some restrictions being placed on self-monitoring, especially for patients with type 2 diabetes, where the evidence for a benefit is less clear-cut.³ With this in mind, we review the data relating to the benefits of self-monitoring in adults with diabetes, particularly those with type 2 disease.

This article has been cited by other articles:

				Preconception care for women with diabetes DTB, May 1, 2008; 46(5): 36 - 40. [Abstract] [Full Text] [PDF]